<?xml version='1.0'?>
<!DOCTYPE art SYSTEM 'http://www.biomedcentral.com/xml/article.dtd'>
<art>
   <ui>bcr1895</ui>
   <ji>BCJ</ji>
   <fm>
      <dochead>Poster presentation</dochead>
      <bibl>
         <title>
            <p><it>NRG1 </it>is frequently silenced by methylation in breast cancers and is a strong candidate for the 8p tumour suppressor gene</p>
         </title>
         <aug>
            <au id="A1">
               <snm>Chua</snm>
               <fnm>Y-L</fnm>
               <insr iid="I1"/>
            </au>
            <au id="A2">
               <snm>Ito</snm>
               <fnm>Y</fnm>
               <insr iid="I2"/>
            </au>
            <au id="A3">
               <snm>Pole</snm>
               <fnm>JCM</fnm>
               <insr iid="I1"/>
            </au>
            <au id="A4">
               <snm>Chin</snm>
               <fnm>S-F</fnm>
               <insr iid="I2"/>
            </au>
            <au id="A5">
               <snm>Ellis</snm>
               <fnm>IO</fnm>
               <insr iid="I3"/>
            </au>
            <au id="A6">
               <snm>Caldas</snm>
               <fnm>C</fnm>
               <insr iid="I2"/>
            </au>
            <au id="A7">
               <snm>O'Hare</snm>
               <fnm>MJ</fnm>
               <insr iid="I4"/>
            </au>
            <au id="A8">
               <snm>Murrell</snm>
               <fnm>AM</fnm>
               <insr iid="I2"/>
            </au>
            <au id="A9">
               <snm>Edwards</snm>
               <fnm>PAW</fnm>
               <insr iid="I1"/>
            </au>
         </aug>
         <insg>
            <ins id="I1">
               <p>Department of Pathology, University of Cambridge, Hutchison/MRC Research Centre, Cambridge, UK</p>
            </ins>
            <ins id="I2">
               <p>CR-UK Cambridge Research Institute, Cambridge, UK</p>
            </ins>
            <ins id="I3">
               <p>Department of Pathology, University of Nottingham, UK</p>
            </ins>
            <ins id="I4">
               <p>Ludwig Institute for Cancer Research Breast Cancer Laboratory, University College, London, UK</p>
            </ins>
         </insg>
         <source>Breast Cancer Research</source>
         <supplement>
            <title>
               <p>Breast Cancer Research 2008</p>
            </title>
            <note>Meeting abstracts</note>
            <url>http://breast-cancer-research.com/supplements/notes/BCR-vol10-suppl2-info.pdf</url>
         </supplement>
         <conference>
            <title>
               <p>Breast Cancer Research 2008</p>
            </title>
            <location>London, UK</location>
            <date-range>13 May 2008</date-range>
            <url>http://www.breastcancercampaign.org/</url>
         </conference>
         <issn>1465-5411</issn>
         <pubdate>2008</pubdate>
         <volume>10</volume>
         <issue>Suppl 2</issue>
         <fpage>P11</fpage>
         <url>http://breast-cancer-research.com/content/10/S2/P11</url>
         <xrefbib>
            <pubid idtype="doi">10.1186/bcr1895</pubid>
         </xrefbib>
      </bibl>
      <history>
         <pub>
            <date>
               <day>13</day>
               <month>5</month>
               <year>2008</year>
            </date>
         </pub>
      </history>
      <cpyrt>
         <year>2008</year>
         <collab>BioMed Central Ltd</collab>
      </cpyrt>
   </fm>
   <bdy>
      <sec>
         <st>
            <p>Background</p>
         </st>
         <p>It has long been suspected that there is an important breast cancer tumour suppressor gene on the short arm of chromosome 8, 8p, and our array CGH data suggest that it may be close to <it>NRG1 </it><abbrgrp><abbr bid="B1">1</abbr></abbrgrp>. <it>NRG1 </it>encodes growth factors that bind to tyrosine kinases ErbB3 and ErbB4, and can both stimulate cell proliferation and apoptosis. <it>NRG1 </it>is also quite frequently broken by chromosome translocations <abbrgrp><abbr bid="B2">2</abbr></abbrgrp>.</p>
      </sec>
      <sec>
         <st>
            <p>Methods and results</p>
         </st>
         <p>By quantitiative PCR, <it>NRG1 </it>expression was repressed or abolished in many breast cancer cell lines and tumours as compared with normal breast. Methylation analysis by sequencing or pyrosequencing bisulphite-treated DNA showed striking DNA methylation at a CpG island in <it>NRG1</it>, which is correlated with an absence of <it>NRG1 </it>transcripts. Treatment of cancer cell lines with 5-aza-2-deoxycytidine reactivated the expression of <it>NRG1 </it>by 7 to 100 times. <it>NRG1 </it>was also methylated in tumour tissue samples while it was not in uncultured normal breast epithelium. Knocking down <it>NRG1 </it>expression by siRNA led to an increase in net cell proliferation.</p>
      </sec>
      <sec>
         <st>
            <p>Conclusion</p>
         </st>
         <p><it>NRG1 </it>could be the 8p tumour suppressor gene. It is located in the right place. It is silenced by methylation or other mechanisms in many breast cancer cell lines and tumours. Functionally, <it>NRG1 </it>expression is antiproliferative &#8211; shown both by our siRNA experiments and older work that showed expression to be proapoptotic to breast cancer cell line MCF7 <abbrgrp><abbr bid="B3">3</abbr></abbrgrp>.</p>
      </sec>
   </bdy>
   <bm>
      <ack>
         <sec>
            <st>
               <p>Acknowledgements</p>
            </st>
            <p>Supported by Breast Cancer Campaign and also Cancer Research UK and the Ludwig Institute for Cancer Research.</p>
         </sec>
      </ack>
      <refgrp>
         <bibl id="B1">
            <title>
               <p>High-resolution analysis of chromosome rearrangements on 8p in breast, colon and pancreatic cancer reveals a complex pattern of loss, gain and translocation</p>
            </title>
            <aug>
               <au>
                  <snm>Pole</snm>
                  <fnm>JC</fnm>
               </au>
               <au>
                  <snm>Courtay-Cahen</snm>
                  <fnm>C</fnm>
               </au>
               <au>
                  <snm>Garcia</snm>
                  <fnm>MJ</fnm>
               </au>
               <au>
                  <snm>Blood</snm>
                  <fnm>KA</fnm>
               </au>
               <au>
                  <snm>Cooke</snm>
                  <fnm>SL</fnm>
               </au>
               <au>
                  <snm>Alsop</snm>
                  <fnm>AE</fnm>
               </au>
               <au>
                  <snm>Tse</snm>
                  <fnm>DM</fnm>
               </au>
               <au>
                  <snm>Caldas</snm>
                  <fnm>C</fnm>
               </au>
               <au>
                  <snm>Edwards</snm>
                  <fnm>PA</fnm>
               </au>
            </aug>
            <source>Oncogene</source>
            <pubdate>2006</pubdate>
            <volume>25</volume>
            <fpage>5693</fpage>
            <lpage>5706</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1038/sj.onc.1209570</pubid>
                  <pubid idtype="pmpid" link="fulltext">16636668</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B2">
            <title>
               <p>A recurrent chromosome breakpoint in breast cancer at the NRG1/neuregulin 1/heregulin gene</p>
            </title>
            <aug>
               <au>
                  <snm>Huang</snm>
                  <fnm>HE</fnm>
               </au>
               <au>
                  <snm>Chin</snm>
                  <fnm>SF</fnm>
               </au>
               <au>
                  <snm>Ginestier</snm>
                  <fnm>C</fnm>
               </au>
               <au>
                  <snm>Bardou</snm>
                  <fnm>VJ</fnm>
               </au>
               <au>
                  <snm>Adelaide</snm>
                  <fnm>J</fnm>
               </au>
               <au>
                  <snm>Iyer</snm>
                  <fnm>NG</fnm>
               </au>
               <au>
                  <snm>Garcia</snm>
                  <fnm>MJ</fnm>
               </au>
               <au>
                  <snm>Pole</snm>
                  <fnm>JC</fnm>
               </au>
               <au>
                  <snm>Callagy</snm>
                  <fnm>GM</fnm>
               </au>
               <au>
                  <snm>Hewitt</snm>
                  <fnm>SM</fnm>
               </au>
               <au>
                  <snm>Gullick</snm>
                  <fnm>WJ</fnm>
               </au>
               <au>
                  <snm>Jacquemier</snm>
                  <fnm>J</fnm>
               </au>
               <au>
                  <snm>Caldas</snm>
                  <fnm>C</fnm>
               </au>
               <au>
                  <snm>Chaffanet</snm>
                  <fnm>M</fnm>
               </au>
               <au>
                  <snm>Birnbaum</snm>
                  <fnm>D</fnm>
               </au>
               <au>
                  <snm>Edwards</snm>
                  <fnm>PA</fnm>
               </au>
            </aug>
            <source>Cancer Res</source>
            <pubdate>2004</pubdate>
            <volume>64</volume>
            <fpage>6840</fpage>
            <lpage>6844</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1158/0008-5472.CAN-04-1762</pubid>
                  <pubid idtype="pmpid" link="fulltext">15466169</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B3">
            <title>
               <p>Neu differentiation factor (NDF), a dominant oncogene, causes apoptosis in vitro and in vivo</p>
            </title>
            <aug>
               <au>
                  <snm>Grimm</snm>
                  <fnm>S</fnm>
               </au>
               <au>
                  <snm>Weinstein</snm>
                  <fnm>EJ</fnm>
               </au>
               <au>
                  <snm>Krane</snm>
                  <fnm>IM</fnm>
               </au>
               <au>
                  <snm>Leder</snm>
                  <fnm>P</fnm>
               </au>
            </aug>
            <source>J Exp Med</source>
            <pubdate>1998</pubdate>
            <volume>188</volume>
            <fpage>1535</fpage>
            <lpage>1539</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="pmcid">2213420</pubid>
                  <pubid idtype="pmpid" link="fulltext">9782131</pubid>
                  <pubid idtype="doi">10.1084/jem.188.8.1535</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
      </refgrp>
   </bm>
</art>

